EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Diagnostic value of serum vascular endothelial growth factor-D in Korean patients with lymphangioleiomyomatosis

Hee-Young Yoon, Su-Jin Moon, Song Yee Kim, Jong Sun Park, Sun Mi Choi iD, Hyung Koo Kang, Jin Woo Song iD

Therapeutic Advances in Respiratory Disease · 2024

DOI: 10.1177/17534666241272928 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2024. Verfasst von Hee-Young Yoon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Respiratory Diseases, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Lymphangioleiomyomatosis, Vascular Endothelial Growth Factor D, Enzyme-Linked Immunosorbent Assay. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lymphangioleiomyomatosis (LAM) is a rare multisystemic disorder characterized by the proliferation of abnormal smooth muscle-like cells. Although serum vascular endothelial growth factor-D (VEGF-D) is currently used as a diagnostic biomarker for LAM, its diagnostic value in Korean patients is unclear.

Objectives

To evaluate the diagnostic value of serum VEGF-D for LAM in Korean patients.

Design

A multicenter prospective cohort study Methods: Serum samples were prospectively collected from five medical institutions, from patients with LAM ( n = 40) and controls ( n = 24; healthy participants = 3, other cystic lung diseases = 13, idiopathic pulmonary fibrosis = 4, idiopathic nonspecific interstitial pneumonia = 4). Serum VEGF-D levels were measured using the enzyme-linked immunosorbent assay, and the diagnostic value was evaluated using receiver operating characteristic (ROC) curve analysis.

Results

The mean age of patients with LAM was 44.5 years, and all were female (controls: 47.8 years; female: 70.8%, p < 0.001). The serum VEGF-D levels were significantly higher in patients with LAM than those in the control group (median: 708.9 pg/mL vs 325.3 pg/mL, p < 0.001). In the ROC curve analysis, serum VEGF-D levels showed good predicting performance for LAM diagnosis (area under the curve = 0.918) with an optimal cut-off value of 432.7 pg/mL (sensitivity = 85.0%, specificity = 87.5%). When 800 pg/mL was used as the cut-off value, the specificity of serum VEGF-D for LAM diagnosis increased to 100.0%.

Conclusion

Our results suggest that serum VEGF-D may be a useful biomarker for diagnosing LAM in Korean patients, similar to previous reports.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphangioleiomyomatosisVascular Endothelial Growth Factor DEnzyme-Linked Immunosorbent AssayHumansFemaleAdultMiddle AgedProspective StudiesRepublic of KoreaCase-Control StudiesROC CurveBiomarkersPredictive Value of TestsLung NeoplasmsCohort StudiesMale

Stichwörter der Autor:innen

biomarkerdiagnosislymphangioleiomyomatosisrare lung diseasevascular endothelial growth factor-D

Substanzen

Vascular Endothelial Growth Factor DVEGFD protein, humanBiomarkers

Autor:innen und Institutionen

  • Division of Allergy and Respiratory Diseases, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.
  • Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.
  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Republic of Korea.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.

ORCID-Profile: Sun Mi Choi, Jin Woo Song

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Yoon, H. Y., Moon, S. J., Kim, S. Y., Park, J. S., Choi, S. M., Kang, H. K., & Song, J. W. (2024). Diagnostic value of serum vascular endothelial growth factor-D in Korean patients with lymphangioleiomyomatosis. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666241272928

Vancouver

Yoon HY, Moon SJ, Kim SY, Park JS, Choi SM, Kang HK, et al. Diagnostic value of serum vascular endothelial growth factor-D in Korean patients with lymphangioleiomyomatosis. Therapeutic Advances in Respiratory Disease. 2024. doi:10.1177/17534666241272928

BibTeX
@article{Yoon2024,
  author = {Yoon, Hee-Young and Moon, Su-Jin and Kim, Song Yee and Park, Jong Sun and Choi, Sun Mi and Kang, Hyung Koo and Song, Jin Woo},
  title = {Diagnostic value of serum vascular endothelial growth factor-D in Korean patients with lymphangioleiomyomatosis},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2024},
  doi = {10.1177/17534666241272928}
}
Kostenlos starten →